Brief Intervention for Substance Use and Partner Abuse Among Females in the ER
NCT ID: NCT01709552
Last Updated: 2015-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2012-03-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention for Battered Sheltered Women With Substance Use Randomized Trial
NCT02629133
Brief Intervention for Problem Drinking and Partner Violence
NCT01207258
Brief Intervention to Reduce Drinking and Intimate Partner Violence in Women
NCT00539812
Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk
NCT01351389
Bystander Intervention for Hazardous Drinking
NCT06543342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Computer Intervention
Patients randomized to the computer intervention will complete the B-SAFER computer program during their emergency department visit.
Computer Intervention
Patients randomized to the computer intervention will complete the B-SAFER computer program during their emergency department visit.
Control
Patients randomized to the control arm will receive a time-equivalent computer-based program unrelated to substance use or partner violence.
Control
Patients randomized to the control arm will receive a time-equivalent computer-based program unrelated to substance use or partner violence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer Intervention
Patients randomized to the computer intervention will complete the B-SAFER computer program during their emergency department visit.
Control
Patients randomized to the control arm will receive a time-equivalent computer-based program unrelated to substance use or partner violence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English or Spanish language proficiency sufficient to understand and complete study procedures
* moderate drug use in the prior 3 months (by NM-ASSIST)
* IPV victimization in the prior 6 months (by WAST)
* access to a phone
Exclusion Criteria
* intoxicated
* medically unstable as determined by ED staff
* suicidal ideation
* psychosis
* combative
* in police custody
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rhode Island Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esther Choo
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esther K Choo, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Rhode Island Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rhode Island Hospital Department of Emergency Medicine
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.